Sign In
29 Nov 2016 09:00
EXOVA GROUP PLC
Notification of transactions of Directors and PDMRs
On 28 November 2016, Paul Barry, a person discharging managerial responsibilities ("PDMR"), sold 29,389 ordinary shares of 1 pence each ("Shares") in Exova Group plc (the "Company") as set out in column 3 in order to discharge tax liabilities arising upon exercise of a bonus share award as set out in the Company's RNS announcement dated 24 November 2016.
1. Name | 2. Status | 3. Number of Shares sold and price per Share |
Paul Barry | PDMR | 29,389 at £1.84 per Share |
Following the sale, Paul Barry's total shareholding in the capital of Exova Group plc is 60,511 ordinary shares, representing 0.02 per cent. of the voting share capital of Exova Group plc.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Paul Barry | |
2 | Reason for the notification | ||
a) | Position/status | PDMR - Group Managing Director, Industries | |
b) | Initial notification / Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Exova Group plc | |
b) | LEI | N/A | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p each
GB00BKY7HG11 | |
b) | Nature of the transaction | Sale of shares in order to discharge tax liabilities arising upon exercise of a bonus share award as set out in the Company's RNS announcement dated 24 November 2016. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
1.84 | 29,389 | ||
d) | Aggregated information - Aggregated volume - Price |
N/A | |
e) | Date of the transaction | 28 November 2016 | |
f) | Place of the transaction | London | |
This notification is made in accordance with Article 19 of the Market Abuse Regulation and the Disclosure and Transparency Rules.
For and on behalf of Exova Group plc
Date: 29 November 2016
Neil MacLennan
General Counsel & Company SecretaryTelephone: 0131 333 8053
About Exova
Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 138 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.
Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Automotive; and Health Sciences.
Follow the stocks
